British researchers have announced the development of a new class of drug that could help treat drug-resistant acute myeloid leukaemia (AML).
The drug ICEC0942 targets the enzyme CDK7, which is involved in the transcription process.
Scientists at...
6 years ago
Research suggests that a novel approach to gene editing could be used in sickle cell anaemia and other red cell diseases by targeting regulators of foetal haemoglobin.
The method involves re-engineering naturally occurring, benign mutations, known...
6 years ago
